tiprankstipranks
Musclepharm Corp (MSLPQ)
:MSLPQ
US Market

MusclePharm (MSLPQ) Financial Statements

Compare
23 Followers

MusclePharm Financial Overview

MusclePharm's market cap is currently $34.00. The company's EPS TTM is $; its P/E ratio is ―; MusclePharm is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 21Dec 20Dec 19Dec 18
Income Statement
Total Revenue$ 50.04M$ 64.44M$ 79.67M$ 88.11M
Gross Profit$ 5.37M$ 19.61M$ 8.69M$ 18.39M
Operating Income$ -7.40M$ 4.86M$ -15.09M$ -6.86M
EBITDA$ -8.91M$ 5.33M$ -14.43M$ -6.01M
Net Income$ -12.88M$ 3.19M$ -18.93M$ -10.76M
Balance Sheet
Cash & Short-Term Investments$ 1.22M$ 2.00M$ 1.53M$ 2.32M
Total Assets$ 11.21M$ 13.00M$ 14.54M$ 24.60M
Total Debt$ 10.71M$ 11.44M$ 11.28M$ 20.73M
Net Debt$ 9.48M$ 9.43M$ 9.75M$ 18.41M
Total Liabilities$ 43.40M$ 37.42M$ 42.49M$ 52.80M
Stockholders' Equity$ -32.19M$ -24.42M$ -27.95M$ -28.20M
Cash Flow
Free Cash Flow$ -8.04M$ -872.00K$ -6.54M$ 1.85M
Operating Cash Flow$ -8.04M$ -868.00K$ -6.52M$ 1.98M
Investing Cash Flow$ -2.00K$ 218.00K$ -13.00K$ -132.00K
Financing Cash Flow$ 7.26M$ 1.12M$ 5.74M$ -5.73M
Currency in USD

MusclePharm Earnings and Revenue History

MusclePharm Debt to Assets

MusclePharm Cash Flow

MusclePharm Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis